These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22285546)

  • 1. Controlled release formulations of IL-2, TGF-β1 and rapamycin for the induction of regulatory T cells.
    Jhunjhunwala S; Balmert SC; Raimondi G; Dons E; Nichols EE; Thomson AW; Little SR
    J Control Release; 2012 Apr; 159(1):78-84. PubMed ID: 22285546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single and combined effect of retinoic acid and rapamycin modulate the generation, activity and homing potential of induced human regulatory T cells.
    Candia E; Reyes P; Covian C; Rodriguez F; Wainstein N; Morales J; Mosso C; Rosemblatt M; Fierro JA
    PLoS One; 2017; 12(7):e0182009. PubMed ID: 28746369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rapamycin and interleukin-2 on regulatory CD4+CD25+Foxp3+ T cells in mice after allogenic corneal transplantation.
    Wang X; Wang W; Xu J; Le Q
    Transplant Proc; 2013 Mar; 45(2):528-37. PubMed ID: 23267787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin combined with allogenic immature dendritic cells selectively expands CD4+CD25+Foxp3+ regulatory T cells in rats.
    Wang GY; Zhang Q; Yang Y; Chen WJ; Liu W; Jiang N; Chen GH
    Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):203-8. PubMed ID: 22484590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-trans retinoic acid and rapamycin synergize with transforming growth factor-β1 to induce regulatory T cells but confer different migratory capacities.
    Jhunjhunwala S; Chen LC; Nichols EE; Thomson AW; Raimondi G; Little SR
    J Leukoc Biol; 2013 Nov; 94(5):981-9. PubMed ID: 23898044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin.
    Asanuma S; Tanaka J; Sugita J; Kosugi M; Shiratori S; Wakasa K; Shono Y; Shigematsu A; Kondo T; Kobayashi T; Asaka M; Imamura M
    Ann Hematol; 2011 Jun; 90(6):617-24. PubMed ID: 21107839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo-expanded but not in vitro-induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the FOXP3 regulatory T cell-specific demethylated region.
    Rossetti M; Spreafico R; Saidin S; Chua C; Moshref M; Leong JY; Tan YK; Thumboo J; van Loosdregt J; Albani S
    J Immunol; 2015 Jan; 194(1):113-24. PubMed ID: 25452562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cells require mammalian target of rapamycin signaling to maintain both homeostasis and alloantigen-driven proliferation in lymphocyte-replete mice.
    Wang Y; Camirand G; Lin Y; Froicu M; Deng S; Shlomchik WD; Lakkis FG; Rothstein DM
    J Immunol; 2011 Mar; 186(5):2809-18. PubMed ID: 21270412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ Treg.
    Biswas M; Sarkar D; Kumar SR; Nayak S; Rogers GL; Markusic DM; Liao G; Terhorst C; Herzog RW
    Blood; 2015 May; 125(19):2937-47. PubMed ID: 25833958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
    Singh AK; Horvath KA; Mohiuddin MM
    Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
    Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y
    Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of porcine-specific regulatory T cells with high specificity and expression of IL-10 and TGF-β1 using baboon-derived tolerogenic dendritic cells.
    Li M; Eckl J; Abicht JM; Mayr T; Reichart B; Schendel DJ; Pohla H
    Xenotransplantation; 2018 Jan; 25(1):. PubMed ID: 29057512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Analysis of Protocols to Induce Human CD4+Foxp3+ Regulatory T Cells by Combinations of IL-2, TGF-beta, Retinoic Acid, Rapamycin and Butyrate.
    Schmidt A; Eriksson M; Shang MM; Weyd H; Tegnér J
    PLoS One; 2016; 11(2):e0148474. PubMed ID: 26886923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined administration of a mutant TGF-beta1/Fc and rapamycin promotes induction of regulatory T cells and islet allograft tolerance.
    Zhang W; Zhang D; Shen M; Liu Y; Tian Y; Thomson AW; Lee WP; Zheng XX
    J Immunol; 2010 Oct; 185(8):4750-9. PubMed ID: 20844194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Brandenburg S; Takahashi T; de la Rosa M; Janke M; Karsten G; Muzzulini T; Orinska Z; Bulfone-Paus S; Scheffold A
    Eur J Immunol; 2008 Jun; 38(6):1643-53. PubMed ID: 18493984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin together with TGF-β1, IL-2 and IL-15 induces the generation of functional regulatory γδT cells from human peripheral blood mononuclear cells.
    Gu Y; Hu Y; Hu K; Liao W; Zheng F; Yu X; Huang H
    J Immunol Methods; 2014 Jan; 402(1-2):82-7. PubMed ID: 24275339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
    Bocian K; Borysowski J; Wierzbicki P; Wyzgal J; Klosowska D; Bialoszewska A; Paczek L; Górski A; Korczak-Kowalska G
    Nephrol Dial Transplant; 2010 Mar; 25(3):710-7. PubMed ID: 19903662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta 1 (TGF-beta1) and rapamycin synergize to effectively suppress human T cell responses via upregulation of FoxP3+ Tregs.
    Kawamoto K; Pahuja A; Hering BJ; Bansal-Pakala P
    Transpl Immunol; 2010 May; 23(1-2):28-33. PubMed ID: 20307666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.